Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cell Conditioned Medium for Cancer Cachexia and Cancer Therapy Side Effects
jRCT1051260124Recruiting
- Sponsor
- Heiwa Clinic
- Start
- Apr 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial in cancer anorexia-cachexia syndrome (CACS), Adverse effects of anticancer therapy (AEs) and cancer, sponsored by Heiwa Clinic. Primary endpoints: Change in clinical condition after one month of treatment, Change in blood biomarkers after one month of treatment and 1 more. Started Apr 2024; status: recruiting.
02
Conditions
cancer anorexia-cachexia syndrome (CACS)Adverse effects of anticancer therapy (AEs)cancer
Beyond the preview
Go deeper on jRCT1051260124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051260124.